Schwartz Investment Counsel Inc Amgen Inc Transaction History

Schwartz Investment Counsel Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $23.8 Million - $26.7 Million	-143,149 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $15.6 Million - $18.2 Million	-92,101 Reduced 39.15%	143,149 $24.4 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $4.89 Million - $5.47 Million	-29,000 Reduced 10.97%	235,250 $0
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $44.2 Million - $50.5 Million	264,250	264,250 $49.3 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Schwartz Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Schwartz Investment Counsel Inc with notifications on news.